Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia

Схожие документы

• Anti-nucleocapsid antibody levels following initial and repeat SARS-CoV-2 infections in a cohort of long-term care facility residents in England (VIVALDI) [version 1; peer review: 2 approved]
  по: Maria Krutikov, и др.
  Опубликовано: (2024-02-01)
• VIVALDI Cohort Profile: Using linked, routinely collected data and longitudinal blood sampling to characterise COVID-19 infections, vaccinations, and related outcomes in care home staff and residents in England [version 2; peer review: 2 approved]
  по: Maria Krutikov, и др.
  Опубликовано: (2024-08-01)
• Protocol for VIVALDI social care: Pilot study to reduce infections, outbreaks and antimicrobial resistance in care homes for older adults [version 1; peer review: 2 approved]
  по: Zoe Fry, и др.
  Опубликовано: (2024-02-01)
• Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia
  по: Thomas Roberts, и др.
  Опубликовано: (2024-01-01)
• VIVALDI-CT shaping care home COVID-19 testing policy: A pragmatic cluster randomised controlled trial of asymptomatic testing compared to standard care in care home staff.
  по: Oliver Stirrup, и др.
  Опубликовано: (2025-01-01)